EWLL (eWellness Healthcare) Research & Development: $0.00 Mil (TTM As of Mar. 2022)


What is eWellness Healthcare Research & Development?

eWellness Healthcare EWLL -90.00% Research & Development is $0.00 Mil as of Mar. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. eWellness Healthcare's Research & Development for the three months ended in Mar. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2022 was $0.00 Mil.


eWellness Healthcare  (OTCPK:EWLL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


eWellness Healthcare Research & Development Related Terms


eWellness Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for eWellness Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

eWellness Healthcare Research & Development Chart

eWellness Healthcare Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

eWellness Healthcare Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

eWellness Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
eWellness Healthcare (EWLL) has a Research & Development of $0.00 Mil as of Mar. 2022. Research and development expense is the total cost for research and development activities. View historical data on eWellness Healthcare and its competitors.
Is eWellness Healthcare's Research & Development too high?
eWellness Healthcare's current Research & Development is $0.00 Mil.
How does eWellness Healthcare's Research & Development compare to HITC and VYND?
eWellness Healthcare's Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on eWellness Healthcare and its competitors. eWellness Healthcare's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is eWellness Healthcare stock overvalued right now?
eWellness Healthcare (EWLL) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For eWellness Healthcare (EWLL), the current Research & Development is $0.00 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

eWellness Healthcare Business Description

Address 1125 S Federal Highway, Suite 464, Fort Lauderdale, FL, USA, 33316
eWellness Healthcare Corp is a physical therapy telehealth company to offer real-time distance monitored treatments. The Company's has PHZIO home physical therapy exercise system.